News about Global Pharma

Gilead Opens State-of-the-Art Research Center to Advance Next Generation Medicines

Gilead opens a new research center in Foster City, bringing together oncology, inflammation and data science teams to advance next-generation medicines.

Global Pharma | 09/09/2026 | By News Bureau |  224

Syntegon Delivers Continued Sales Growth and Margin Expansion in First-Half

Syntegon reports 7 percent sales growth to €883 million in H1 2026, driven by a 14 percent increase in pharma sales and continued margin expansion.

Global Pharma | 08/09/2026 | By News Bureau |  103

WHO Validates Timor-Leste's Elimination of Trachoma as Public Health Problem

WHO validates Timor-Leste’s elimination of trachoma, making it the 33rd country globally to achieve the milestone and ending the disease’s public health status across the South-East Asia Region.

Global Pharma | 04/09/2026 | By News Bureau |  101

RPG Life Sciences Subsidiary to Acquire Raghava Life Sciences' API Business for Up to INR 135 Crore

RPG Active Pharma’s latest acquisition expands its manufacturing capacity, API portfolio and regulatory capabilities as part of its buy-and-build strategy.

Global Pharma | 03/09/2026 | By Akanki |  147

Sanner Group Appoints New CBDO to Accelerate Global Growth Strategy

Sanner Group appoints Jean-Edouard Rabier as Chief Business Development Officer (CBDO) to accelerate its global growth strategy, leveraging his 20+ years of pharmaceutical and healthcare experience.

Global Pharma | 03/09/2026 | By News Bureau |  123

Syntegon Opens New OSD Customer Center in Fellbach

Syntegon opens a new state-of-the-art OSD Customer Center in Fellbach to drive innovation and accelerate time-to-market for pharma and nutraceutical products.

Global Pharma | 03/09/2026 | By News Bureau

Teva Pharma and Trump Administration Plan Agreement on Affordable Medicines

Teva Pharma plans an agreement with the Trump Administration to align US Medicaid pricing for select medicines with leading developed markets under the GENEROUS framework.

Global Pharma | 02/09/2026 | By News Bureau |  107

Sun Pharma Participates in White House Signing Ceremony Highlighting US Medicines Pricing and Access Commitments

Sun Pharma joins White House ceremony highlighting US medicines pricing and access commitments, strengthening its presence across dermatology, immunology and generics.

Global Pharma | 01/09/2026 | By News Bureau |  104

RNA Breakthrough Offers Hope for Thousands of Untreatable Diseases

Researchers at University of Toronto, University Health Network and SickKids develop engineered tRNA as a potential RNA therapeutic platform for thousands of untreatable diseases.

Global Pharma | 31/08/2026 | By News Bureau |  104

AbbVie Seeks EMA Approval for Subcutaneous SKYRIZI in Crohn's Disease

AbbVie submits an European Medicines Agency (EMA) application for subcutaneous SKYRIZI induction in adults with moderately to severely active Crohn’s Disease (CD), supported by phase 3 AFFIRM data.

Global Pharma | 27/08/2026 | By News Bureau |  104